Skip to main content
Figure 4 | Critical Care

Figure 4

From: A high angiopoietin-2/angiopoietin-1 ratio is associated with a high risk of septic shock in patients with febrile neutropenia

Figure 4

Twenty-eight-day survival and septic shock development in high-risk FN patients. Kaplan-Meier estimates of 28-day (a) survival and (b) septic shock development of patients with febrile neutropenia (FN) according to angiopoietin (Ang)-2/Ang-1 ratio. The ratio was dichotomized by the median Ang-2/Ang-1 ratio (2.2) in all patients (right) or by an optimal cut-off level of 5.0 (left), defined by a receiver operator characteristic (ROC) analysis.

Back to article page